Ceribell (CBLL) Total Current Liabilities (2023 - 2026)
Ceribell (CBLL) posted Total Current Liabilities of $16.2 million for Q1 2026, down 15.66% on a QoQ basis from $19.2 million in Q4 2025, and up 36.79% year-over-year from $11.8 million in Q1 2025.
Ceribell (CBLL) Total Current Liabilities (2023 - 2026) Analysis & Trends
Ceribell's Total Current Liabilities history runs 4 years deep, the most recent figure standing at $16.2 million for Q1 2026.
- Quarterly Total Current Liabilities rose 36.79% year-over-year to $16.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.2 million (up 36.79% YoY) and the FY2025 annual result came in at $19.2 million, up 47.74% from the prior year.
- Total Current Liabilities was $16.2 million for Q1 2026 at Ceribell, down from $19.2 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $21.6 million in Q4 2023 and bottomed at $11.8 million in Q1 2025.
- A 4-year average of $15.6 million and a median of $15.1 million in 2025 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Current Liabilities plunged 39.87% — and 2025, when it surged 47.74%.
- Ceribell's Total Current Liabilities stood at $21.6 million in 2023, then plunged by 39.87% to $13.0 million in 2024, then jumped by 47.74% to $19.2 million in 2025, then retreated by 15.66% to $16.2 million in 2026.
- Business Quant data shows CBLL's Total Current Liabilities at $16.2 million in Q1 2026, $19.2 million in Q4 2025, and $15.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Ceribell | 613.16 Mn | 471.97 Mn | 23.12 Mn | 16.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.18 Mn |
| Dec 31, 2025 | 19.19 Mn |
| Sep 30, 2025 | 15.17 Mn |
| Jun 30, 2025 | 15.01 Mn |
| Mar 31, 2025 | 11.83 Mn |
| Dec 31, 2024 | 12.99 Mn |
| Sep 30, 2024 | 13.09 Mn |
| Dec 31, 2023 | 21.60 Mn |